← Evidence map

ArticleJournal of clinical tuberculosis and other mycobacterial diseases2021

Should treatment of low-level rifampicin mono-resistant tuberculosis be different?

Armand Van Deun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 34095546